Aleksandra Drelich
The University of Texas Medical Branch at Galveston(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research, Computational Drug Discovery Methods, Virus-based gene therapy research
Most-Cited Works
- → A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2(2020)160 cited
- → A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**(2020)130 cited
- → High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models(2020)129 cited
- → A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells(2021)117 cited
- → Bepridil is potent against SARS-CoV-2 in vitro(2021)109 cited
- → Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection(2020)92 cited
- → Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro(2020)84 cited
- → Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L(2021)83 cited
- → Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection(2021)78 cited
- → A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering(2021)69 cited